{"transactions":[{"id":697197,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-04T20:30:31.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7468,"price":9.69,"value":72364.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on August 1, 2026."}],"balance_after":205541,"source":{"system":"sec-edgar","filing":"0001700659-26-000016","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000016/primarydocument.xml","form_type":"4"}},{"id":715277,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":64812,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2161},"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":715276,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":2161,"price":13.64,"value":29476.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":715275,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":2161,"price":7.86,"value":16985.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":215170,"source":{"system":"sec-edgar","filing":"0001700659-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000014/primarydocument.xml","form_type":"4"}},{"id":721230,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":36725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 103,698 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 2, 2026, and the balance vests\nin equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer"}],"balance_after":66973,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":36725},"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721229,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":36725,"price":12.86,"value":472283.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721228,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":36725,"price":7.86,"value":288658.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":249734,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":721227,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-02T00:08:30.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":19608,"price":11.04,"value":216472.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.00 to $11.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to\nprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213009,"source":{"system":"sec-edgar","filing":"0001700659-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000012/primarydocument.xml","form_type":"4"}},{"id":780846,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-13T21:18:54.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":15309,"price":11.02,"value":168705.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.00 to $11.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to\nprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":232617,"source":{"system":"sec-edgar","filing":"0001700659-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000010/primarydocument.xml","form_type":"4"}},{"id":846120,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T22:17:39.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":5124,"price":10.35,"value":53033.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":247926,"source":{"system":"sec-edgar","filing":"0001700659-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000008/primarydocument.xml","form_type":"4"}},{"id":921899,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:46:40.000Z","date":"2026-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5267,"price":11.16,"value":58779.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on February 1, 2026."}],"balance_after":253050,"source":{"system":"sec-edgar","filing":"0001700659-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000006/primarydocument.xml","form_type":"4"}},{"id":943251,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:44:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":35402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":35402,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":35402},"source":{"system":"sec-edgar","filing":"0001700659-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000004/primarydocument.xml","form_type":"4"}},{"id":943250,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:44:39.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":65847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":258317,"source":{"system":"sec-edgar","filing":"0001700659-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000004/primarydocument.xml","form_type":"4"}},{"id":946818,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:31:06.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":18247,"price":14.4,"value":262756.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":192470,"source":{"system":"sec-edgar","filing":"0001700659-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000170065926000003/primarydocument.xml","form_type":"4"}},{"id":1177657,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-04T21:17:02.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5263,"price":8.07,"value":42472.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on February 1, 2025"}],"balance_after":210717,"source":{"system":"sec-edgar","filing":"0001562180-25-003009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025003009/primarydocument.xml","form_type":"4"}},{"id":1310750,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":103698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":103698,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":103698},"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1310749,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":64293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer."}],"balance_after":215980,"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1310748,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:39.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":13891,"price":7.73,"value":107377.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024."}],"balance_after":151687,"source":{"system":"sec-edgar","filing":"0001562180-25-000190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218025000190/primarydocument.xml","form_type":"4"}},{"id":1440809,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-05T22:41:59.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":58386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer."}],"balance_after":165578,"source":{"system":"sec-edgar","filing":"0001562180-24-006017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024006017/primarydocument.xml","form_type":"4"}},{"id":1589212,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-07T23:05:43.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":12878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 44,155 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2024, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer"}],"balance_after":31277,"derivative":{"exercise_price":22.25,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":12878},"source":{"system":"sec-edgar","filing":"0001562180-24-002430","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024002430/primarydocument.xml","form_type":"4"}},{"id":1589211,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-07T23:05:43.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":12878,"price":28.36,"value":365220.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":107192,"source":{"system":"sec-edgar","filing":"0001562180-24-002430","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024002430/primarydocument.xml","form_type":"4"}},{"id":1589210,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-07T23:05:43.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":12878,"price":22.25,"value":286535.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":120070,"source":{"system":"sec-edgar","filing":"0001562180-24-002430","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024002430/primarydocument.xml","form_type":"4"}},{"id":1687904,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-01-04T21:23:43.000Z","date":"2024-01-02","kind":"grant","planned":true,"acquired":true,"shares":50875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer."}],"balance_after":50875,"derivative":{"exercise_price":18.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":50875},"source":{"system":"sec-edgar","filing":"0001562180-24-000252","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024000252/primarydocument.xml","form_type":"4"}},{"id":1687903,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:23:43.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":17237,"price":17.3922,"value":299789.3514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $17.05 to $17.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at\nwhich the transaction was effected."}],"balance_after":107192,"source":{"system":"sec-edgar","filing":"0001562180-24-000252","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024000252/primarydocument.xml","form_type":"4"}},{"id":1687902,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:23:43.000Z","date":"2024-01-02","kind":"grant","planned":true,"acquired":true,"shares":32051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer."}],"balance_after":124429,"source":{"system":"sec-edgar","filing":"0001562180-24-000252","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024000252/primarydocument.xml","form_type":"4"}},{"id":1687901,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:23:43.000Z","date":"2024-01-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":10385,"price":17.95,"value":186410.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023."}],"balance_after":92378,"source":{"system":"sec-edgar","filing":"0001562180-24-000252","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218024000252/primarydocument.xml","form_type":"4"}},{"id":2062801,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-01-05T21:06:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":44155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer."}],"balance_after":44155,"derivative":{"exercise_price":22.25,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":44155},"source":{"system":"sec-edgar","filing":"0001562180-23-000222","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218023000222/primarydocument.xml","form_type":"4"}},{"id":2062800,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-05T21:06:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":90588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer."}],"balance_after":102763,"source":{"system":"sec-edgar","filing":"0001562180-23-000222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218023000222/primarydocument.xml","form_type":"4"}},{"id":2062799,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-05T21:06:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":3138,"price":22.1668,"value":69559.4184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $22.0000 to $22.3800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at\nwhich the transaction was effected."}],"balance_after":12175,"source":{"system":"sec-edgar","filing":"0001562180-23-000222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218023000222/primarydocument.xml","form_type":"4"}},{"id":2062798,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-05T21:06:21.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":1837,"price":22.68,"value":41663.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022."}],"balance_after":15313,"source":{"system":"sec-edgar","filing":"0001562180-23-000222","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218023000222/primarydocument.xml","form_type":"4"}},{"id":2449469,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:05:30.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer."}],"balance_after":42500,"derivative":{"exercise_price":34.31,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001562180-22-000159","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218022000159/primarydocument.xml","form_type":"4"}},{"id":2449468,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:05:30.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer."}],"balance_after":17150,"source":{"system":"sec-edgar","filing":"0001562180-22-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218022000159/primarydocument.xml","form_type":"4"}},{"id":2449467,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:05:30.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1598,"price":33.75,"value":53932.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.72 to $33.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8250,"source":{"system":"sec-edgar","filing":"0001562180-22-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218022000159/primarydocument.xml","form_type":"4"}},{"id":2449466,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:05:30.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":1152,"price":32.7,"value":37670.4,"ownership":{"direct":true},"balance_after":9848,"source":{"system":"sec-edgar","filing":"0001562180-22-000159","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218022000159/primarydocument.xml","form_type":"4"}},{"id":2915929,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T13:54:27.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":49700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":49700,"derivative":{"exercise_price":44.97,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":49700},"source":{"system":"sec-edgar","filing":"0001562180-21-000142","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218021000142/primarydocument.xml","form_type":"4"}},{"id":2915928,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-06T13:54:27.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001562180-21-000142","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218021000142/primarydocument.xml","form_type":"4"}},{"id":3318622,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T21:22:56.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer."}],"balance_after":42600,"derivative":{"exercise_price":38.99,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0001562180-20-000217","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218020000217/primarydocument.xml","form_type":"4"}},{"id":3552135,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-19T20:14:07.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following April 17, 2020 while the optionee provides continuous service to the Issuer."}],"balance_after":95000,"derivative":{"exercise_price":54.72,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001562180-19-002311","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000156218019002311/primarydocument.xml","form_type":"4"}},{"id":3646258,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-20T21:54:48.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date date."}],"balance_after":125000,"derivative":{"exercise_price":3.27,"expiration_date":"2029-02-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-19-004277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000089924319004277/doc4.xml","form_type":"4"}},{"id":3957251,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":26650,"kind":"person","name":"PAKOLA STEVE","position":1,"cik":"0001700659","reported_name":"PAKOLA STEVE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-26T00:23:28.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options exercisable as to 1/4th on the first anniversary of the vesting start date and an additional 1/48th monthly thereafter until the fourth anniversary of the vesting start date."}],"balance_after":100000,"derivative":{"exercise_price":3.59,"expiration_date":"2028-04-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-010746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1700659/000089924318010746/doc4.xml","form_type":"4"}}]}